Trend — Autologous platelet rich plasma (prp) or other blood-derived product for diabetic chronic wounds/ulcers, using an fda-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other (G0465) in Medicare, the United States
The full twelve-year services and payments series for this market — per-year values, with the FFS-enrollment denominator beside each.
The compound annual growth for G0465 in the United States — endpoints exclude the introduction year; an Exclude 2020–21 view drops the pandemic years too.